1.
Rahmani TP, Harahap Y, Purwanto DJ. A review of the relationship between Doxorubicin and Doxorubicinol, CBR1 polymorphism, and cardiotoxicity. Pharm Educ [Internet]. 2024 Jun. 14 [cited 2026 Jul. 14];24(6):p. 105-115. Available from: https://pharmacyeducation.fip.org/pharmacyeducation/article/view/2719